Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease

Louise F. Risnes, Asbjørn Christophersen, Shiva Dahal‐Koirala, Ralf S. Neumann, Geir Kjetil Sandve, Vikas K. Sarna, Knut E. A. Lundin, Shuo‐Wang Qiao, Ludvig M. SollidJournal of Clinical Investigation 2018 · DOI

Abstract

Little is known about the repertoire dynamics and persistence of pathogenic T cells in HLA-associated disorders. In celiac disease, a disorder with a strong association with certain HLA-DQ allotypes, presumed pathogenic T cells can be visualized and isolated with HLA-DQ:gluten tetramers, thereby enabling further characterization. Single and bulk populations of HLA-DQ:gluten tetramer-sorted CD4+ T cells were analyzed by high-throughput DNA sequencing of rearranged TCR-α and -β genes. Blood and gut biopsy samples from 21 celiac disease patients, taken at various stages of disease and in intervals of weeks to decades apart, were examined. Persistence of the same clonotypes was seen in both compartments over decades, with up to 53% overlap between samples obtained 16 to 28 years apart. Further, we observed that the recall response following oral gluten challenge was dominated by preexisting CD4+ T cell clonotypes. Public features were frequent among gluten-specific T cells, as 10% of TCR-α, TCR-β, or paired TCR-αβ amino acid sequences of total 1813 TCRs generated from 17 patients were observed in 2 or more patients. In established celiac disease, the T cell clonotypes that recognize gluten are persistent for decades, making up fixed repertoires that prevalently exhibit public features. These T cells represent an attractive therapeutic target.

Introduction

Celiac disease (CD) is a chronic inflammatory condition where the immune system attacks the small intestine in response to gluten. While CD4+ T cells recognizing gluten peptides (presented by HLA-DQ molecules) are known to be the primary drivers, the long-term "memory" of this response has remained poorly understood. A critical question for clinical management is whether pathogenic T cells disappear during a gluten-free diet (GFD) or persist as "immunological scars," ready to reactivate upon re-exposure. This study investigates the longevity and stability of these pathogenic T cell clonotypes over intervals ranging from weeks to nearly 30 years.

Methods

Researchers utilized a sophisticated pipeline to track rare gluten-specific T cells across 21 patients:

  • Tetramer Sorting: HLA-DQ:gluten tetramers were used to isolate T cells specifically recognizing gluten epitopes.
  • High-Throughput Sequencing: DNA sequencing of rearranged TCR-α and TCR-β genes identified unique "clonotypes"—genetic signatures of specific T cell lineages. A total of 1,813 unique paired TCR-αβ sequences were generated.
  • Longitudinal Analysis: Blood and gut biopsy samples were analyzed, including unique access to cryopreserved historic samples from the late 1980s and 1990s.
  • Gluten Challenge: Treated patients on a GFD underwent a 14-day oral gluten challenge to observe the acute recall response.

Results

Decadal Persistence and the "Immunological Scar"

The study revealed that pathogenic T cell clones are not transient. Once sensitized to gluten, these specific lineages persist for decades. Analysis of samples taken 16 to 28 years apart showed up to 53% overlap in clonotypes. This stability suggests that the immune system maintains a "fixed" repertoire of inflammatory cells that act as a permanent record of the disease.

Persistence of gluten-specific T cell clonotypes over time (Panel C).

Clonal Contraction and Recall Dominance

While the absolute frequency of gluten-specific T cells in the blood and gut drops significantly after starting a GFD, the underlying diversity of the repertoire remains intact. The cells contract into a dormant memory state rather than disappearing. When gluten is reintroduced, the "recall" response is almost entirely driven by the expansion of these preexisting memory T cells rather than the recruitment of new ones.

Dynamics of gluten-specific CD4+ T cells in blood and gut (Panels A and B).

Blood-Gut Correlation and Public Repertoires

The researchers confirmed that gluten-specific T cells in the peripheral blood accurately reflect the repertoire found in the gut mucosa, validating the potential for blood-based monitoring. Furthermore, approximately 10% of the TCR sequences were "public," meaning identical or near-identical receptors were found in multiple unrelated patients. This suggests that the immune failure in celiac disease often follows predictable, shared structural pathways.

Discussion and Future Directions

The persistence of these "bad actor" clones for decades makes them ideal targets for precision immunotherapy. Rather than broad immunosuppression, future treatments might selectively eradicate these specific, persistent gluten-specific clones. Furthermore, the identification of public TCR motifs opens the door for non-invasive, blood-based diagnostic tests that could identify celiac disease without requiring a biopsy or a prolonged gluten challenge.

While the reported persistence is striking, the authors note that sampling depth remains a limitation; the actual overlap over decades may be even higher than current sequencing can detect.

Summary updated

Abstract

Little is known about the repertoire dynamics and persistence of pathogenic T cells in HLA-associated disorders. In celiac disease, a disorder with a strong association with certain HLA-DQ allotypes, presumed pathogenic T cells can be visualized and isolated with HLA-DQ:gluten tetramers, thereby enabling further characterization. Single and bulk populations of HLA-DQ:gluten tetramer-sorted CD4+ T cells were analyzed by high-throughput DNA sequencing of rearranged TCR-α and -β genes. Blood and gut biopsy samples from 21 celiac disease patients, taken at various stages of disease and in intervals of weeks to decades apart, were examined. Persistence of the same clonotypes was seen in both compartments over decades, with up to 53% overlap between samples obtained 16 to 28 years apart. Further, we observed that the recall response following oral gluten challenge was dominated by preexisting CD4+ T cell clonotypes. Public features were frequent among gluten-specific T cells, as 10% of TCR-α, TCR-β, or paired TCR-αβ amino acid sequences of total 1813 TCRs generated from 17 patients were observed in 2 or more patients. In established celiac disease, the T cell clonotypes that recognize gluten are persistent for decades, making up fixed repertoires that prevalently exhibit public features. These T cells represent an attractive therapeutic target.
BibTeX
@article{risnes2018disease,
  author = {Louise F. Risnes and Asbjørn Christophersen and Shiva Dahal‐Koirala and Ralf S. Neumann and Geir Kjetil Sandve and Vikas K. Sarna and Knut E. A. Lundin and Shuo‐Wang Qiao and Ludvig M. Sollid},
  title = {{Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease}},
  journal = {Journal of Clinical Investigation},
  year = {2018},
  doi = {10.1172/jci98819},
}
Figure